DDrare: Database of Drug Development for Rare Diseases

42. 結節性多発動脈炎
［臨床試験数：14，薬物数：27（DrugBank：16），標的遺伝子数：26，標的パスウェイ数：102］

Searched query = "Polyarteritis nodosa", "PAN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Anti-thymocyte globulin; Azathioprine; CYCLOPHOSPHAMIDE; CellCept; CellCept (Mycophenolate Mofetil); Colchicine; Corticosteroid; Corticosteroid and azathioprine; Cyclophosphamide; Cyclophosphamide, Azathioprine,prednisone,methylprednisolone; Cyclosporine; Dapsone; Filgrastim; Infliximab; Lamivudine; Methotrexate; Methylprednisolone; Mycophenolate; Mycophenolate mofetil; Mycophenolate mofetil,methotrexate; Naltrexone; Naltrexone Hydrochloride; Prednisone; Prednisone, methylprednisolone,cyclophosphamides; Procedure: Autologous Peripheral Blood Stem Cell Transplantation; Rituximab; Tocilizumab

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00001457 (ClinicalTrials.gov)	September 1995	3/11/1999	Lamivudine for Chronic Hepatitis B	Lamivudine for Chronic Hepatitis B	Chronic Hepatitis B;Chronic Hepatitis D;Glomerulonephritis;Polyarteritis Nodosa	Drug: Lamivudine	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	NULL	Completed	N/A	N/A	Both	60	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00001457
(ClinicalTrials.gov)

September 1995

3/11/1999

Lamivudine for Chronic Hepatitis B

Chronic Hepatitis B;Chronic Hepatitis D;Glomerulonephritis;Polyarteritis Nodosa

Drug: Lamivudine

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NULL

Completed

N/A

Both

Phase 2

United States